|
|
 |
 |
| |
 Printable version |
Advanced non‐small‐cell lung cancer: benefit of chemotherapy in symptom control |
Bulletin du Cancer. Volume 90, Number 10, 917-8, Octobre 2003, Tribune libre
|
 Résumé
Article gratuit
|
Author(s) : Jacques Margery, Sylvestre Le Moulec, Frédéric Grassin, Olivier Bauduceau, Jean‐Marc Dot, Lionel Vedrine, François Natali, Joël Guigay |
Summary : Chemotherapy in advanced non‐small‐cell lung cancer may be a controversy because it is only palliative and costly. Benefit of chemotherapy is nevertheless clear in survival and particularly life quality. Beside this technical criteria, two other factors have an impact on the therapeutic decision: symptom control and patient‘s personal expectations. The aim of the strategy is to determine an acceptable compromise in each situation. ▴ |
Keywords : non‐small‐cell lung cancer, chemotherapy, symptom control, cancer patient‘s expectation |
|
